Pantoprazole sodium enteric-coated tablets are mainly indicated for reflux esophagitis, active gastric ulcers and duodenal ulcers, Droe-Ayer’s syndrome and so on. Specific advice to consult a specialist, the dosage should follow the doctor’s instructions.
Pantoprazole sodium enteric-coated tablets is a common acid inhibitor, specific effect on the gastric mucosa wall cells, thereby inhibiting gastric acid secretion, can treat a variety of common esophageal and gastric diseases. This drug is enteric-coated tablets, and should not be chewed when taking the drug, so as not to affect the efficacy of the drug.
Common adverse reactions are dizziness, insomnia, drowsiness, diarrhea, etc. When large doses are taken, transaminase elevation, heart rate abnormality, renal function abnormality, etc., which can be improved after stopping the drug.
Contraindications for this drug are lactating women, women in the first trimester of pregnancy, infants and children. Caution is advised in cases of hepatic and renal insufficiency. It should also be avoided in women after the third trimester of pregnancy due to insufficient data on pregnant women.
Those who are suspected of having esophageal or gastric disorders are advised to consult a doctor in time and not to take medication on their own for treatment.